Ria Diagnostics

Ria Diagnostics — FDA 510(k) Submissions

Ria Diagnostics has submitted 7 FDA 510(k) premarket notifications since 1978, of which 7 received clearance as substantially equivalent to a predicate device.

The company's most frequent device categories include Antigen, Antiserum, Control, Antithrombin Iii, Radioimmunoassay, Theophylline, Radioimmunoassay, Thyroid-stimulating Hormone, Radioimmunoassay, Digoxin (125-i), Rabbit Antibody, Solid Phase Sep., Radioimmunoassay, Total Triiodothyronine . Use the specialty filter in the sidebar to narrow results.